Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2019, Article ID 4325946, 7 pages
https://doi.org/10.1155/2019/4325946
Research Article

Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel

1Medical Oncology Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy
2University of Pavia, Ph.D. in Experimental Medicine, Pavia 27100, Italy
3Medical Physics Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy
4Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan 20090, Italy
5Nuclear Medicine Research Department, Iason, Graz, Austria
6Nuclear Medicine Department, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic
7Scientific Direction, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy
8Nuclear Medicine Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy
9Nuclear Medicine Unit, IRCCS San Raffaele Scientific Institute, Milan 20132, Italy
10Translational Oncology Unit, ICS Maugeri SpA SB-IRCCS, Pavia 27100, Italy
11University of Pavia, Department of Internal Medicine, Pavia 27100, Italy

Correspondence should be addressed to E. Quaquarini; ti.ireguamsci@inirauqauq.acire

Received 7 December 2018; Accepted 19 February 2019; Published 26 March 2019

Academic Editor: Gaurav Malviya

Copyright © 2019 E. Quaquarini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

E. Quaquarini, D. D’Ambrosio, F. Sottotetti, et al., “Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel,” Contrast Media & Molecular Imaging, vol. 2019, Article ID 4325946, 7 pages, 2019. https://doi.org/10.1155/2019/4325946.